Three-Statement Breakdown
REVENUE DOWN
Revenue fell 20% year over year to $3.0B, and carried a 17.6% net margin.
REVENUE
-19.8%
2,960
GROSS PROFIT
—
—
NET INCOME
-46.1%
522
EPS (DILUTED)
-45.5%
$2.19
| Income statement | 24-09 | 24-12 | 25-03 | 25-06 | 25-09 | 25-12 | 26-03 | QoQ | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 648 | 2,001 | 2,196 | 3,690 | 2,966 | 3,272 | 4,397 | 2,960 | -32.7% | -19.8% | |
| SG&A | (39) | (53) | (47) | (40) | (45) | (49) | (63) | (50) | -20.6% | +25.0% | |
| Operating income | -155 | -386 | -268 | 1,269 | 725 | 745 | 1,531 | 661 | -56.8% | -47.9% | |
| Interest expense | (20) | (64) | (59) | (60) | (57) | (59) | (59) | (43) | -27.1% | -28.3% | |
| Income tax | -44 | -22 | -70 | (260) | (139) | (134) | (330) | (150) | -54.5% | -42.3% | |
| Net income | -114 | -399 | -249 | 968 | 547 | 553 | 1,159 | 522 | -55.0% | -46.1% | |
| EPS (diluted) |
NOT DISCLOSED
10-Q
|
-$0.85 | — | -$1.06 | $4.02 | $2.28 | — | $4.81 | $2.19 | -54.5% | -45.5% |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-28 ↗